Global Markets and Technologies for Advanced Drug Delivery Systems - Focus on Routes of Administration
상품코드:1895160
리서치사:BCC Research
발행일:2025년 12월
페이지 정보:영문 339 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계 첨단 약물 전달 시스템(ADDS) 시장 규모는 2025년 2,996억 달러 규모로 추정되며, 2030년 말에는 4,874억 달러에 달할 것으로 예측됩니다.
2025년부터 2030년까지 10.2%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다.
북미의 ADDS 시장은 2025년 1,656억 달러에서 2030년 말에는 2,699억 달러에 달할 것으로 예측됩니다. 2025년부터 2030년까지 연평균 복합 성장률(CAGR)은 10.3%로 예측됩니다.
아시아태평양의 ADDS 시장은 2025년 383억 달러에서 2025년부터 2030년까지 연평균 10.9% 성장하여 2030년 말에는 641억 달러에 달할 것으로 예측됩니다.
세계의 첨단 약물 전달 시스템(Advanced Drug Delivery Systems) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 기술 동향, 규제 환경, 시장 규모 추이 및 예측, 각종 부문별/지역별 상세 분석, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 요약
시장 역학과 성장요인
신기술
부문 분석
지역 분석
결론
제2장 시장 개요
개요
거시경제 요인 분석
미국 관세 제약 업계에 대한 영향
의료비
고령화 사회
지정학적 리스크, 무역 전쟁, 공급망 혼란
세계 경제 성장(GDP) 제약 업계에 대한 영향
Porter의 Five Forces 분석
제3장 시장 역학
시장 역학
시장 성장 촉진요인
만성질환 발생률 증가
약물 전달 진보 나노테크놀러지
치료학과 재료 과학 진보
기업에 의한 연구개발비 증가
정부 자금과 의약품 연구개발비 증가
시장 성장 억제요인
루트 고유 장벽
나노테크놀러지와 나노입자 한계
나노 약물전달 과제
시장 기회
첨단 약물 전달 시스템 비용 효율
약제 내성 극복 나노입자 메커니즘
신흥 시장
제4장 규제 상황
개요
미국
유럽
아시아태평양
제5장 신기술과 파이프라인 분석
개요
AI와 머신러닝(ML)
3D 프린팅
스마트 약물전달 시스템
임상시험 분석
임상시험 분석 : 연구 유형별
임상시험 분석 : 현황별
임상시험 분석 : 단계별
중요 포인트
특허 분석
특허 : 주요 출원인별
특허 : 관할 별
중요 포인트
제6장 시장 세분화 분석
세분화 내역
세계의 첨단 약물 전달 시스템 시장 : 투여 경로별
중요 포인트
경장 경로
비경구 경로
호흡기 경로
경피경로
임플란트
안과
기타
세계의 첨단 약물 전달 시스템 시장 : 기술별
중요 포인트
표적 방출 약물 전달
서방형 약물전달
지연 방출 약물 전달
즉시 방출 약물 전달
맥동 방출 약물 전달
세계의 첨단 약물 전달 시스템 시장 : 매체/캐리어 별
중요 포인트
나노입자
단일클론항체
리포솜
포리마세라퓨티크스
프로드러그
미립자
기타
세계의 첨단 약물 전달 시스템 시장 : 용도별
중요 포인트
종양
심혈관 질환
호흡기 질환
자가면역질환
염증성 질환
대사성 질환
위장 장애
안과
기타
분석 지역
세계의 첨단 약물 전달 시스템 시장 : 지역별
중요 포인트
북미
유럽
아시아태평양
중동 및 아프리카
남미
제7장 경쟁 정보
중요 포인트
경쟁 구도
기업 점유율 분석
제8장 첨단 약물 전달 시스템 시장 지속가능성 : ESG 관점
ESG : 서론
첨단 약물 전달 시스템 시장 지속가능성
ESG 시점
환경에 대한 영향
사회에 대한 영향
거버넌스 영향
ESG 리스크 평가
결론
제9장 부록
조사 방법
약어
출전
기업 개요
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BAXTER
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI
첨단 약물 전달 시스템 시장 신규 기업
LSH
영문 목차
영문목차
The global market for advanced drug delivery systems (ADDS) is estimated to grow from $299.6 billion in 2025 and projected to reach $487.4 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.2% from 2025 to 2030.
The North American market for ADDS is estimated to grow from $165.6 billion in 2025 and projected to reach $269.9 billion by the end of 2030, at a CAGR of 10.3% from 2025 to 2030.
The Asia-Pacific market for ADDS is estimated to grow from $38.3 billion in 2025 and projected to reach $64.1 billion by the end of 2030, at a CAGR of 10.9% from 2025 to 2030.
Report Scope
The current report provides detailed information on advanced drug delivery systems (ADDS). This report analyzes the market trends of ADDS with data from 2024, estimates for 2025, projections of compound annual growth rates through 2030 (forecast period 2025-2030) and regional markets of advanced drug delivery systems. This report highlights the advanced drug delivery systems' current and future market potential of ADDS and provides a detailed analysis of the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities, as well as market projections for 2030 and the market shares of leading manufacturers.
The market is segmented by routes of administration into enteral, parenteral, nasal, transdermal, implant, ophthalmic and other routes. Enteral routes are sub-segmented into oral, sublingual, buccal and rectal. Parenteral routes are sub-segmented into intravenous, subcutaneous and intramuscular. The respiratory route is sub-segmented into intranasal and inhalational.
The market is segmented by technology into targeted-release drug delivery, extended-release drug delivery, delayed-release drug delivery, immediate-release drug delivery and pulsatile-release drug delivery. Based on vehicle/carriers, the market scope is segmented into nanoparticles, monoclonal antibodies, liposomes, polymer therapeutics, prodrugs, microparticles and others.
The market is segmented by application into oncological, cardiovascular, respiratory, autoimmune, inflammatory, metabolic, as well as gastrointestinal disorders, ophthalmic and other therapeutics.
The market has been segmented into significant geographical regions: North America, Europe, Asia-Pacific, the Middle East and Africa (MEA) and South America. The regional segment will include a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia and India. For market estimates, data will be provided for 2024 as the base year, with forecast values for 2025 through 2030.
The report aims to:
Analyze types of ADDS.
Analyze global market size and segmentation.
Understand market constraints and drivers.
Provide detailed market forecasts for 2030.
Assess market shares, competitiveness and industry structure.
Identify potential long-term impacts on the advanced drug delivery systems market.
Report Includes
170 data tables and 79 additional tables
Overview and an analysis of the global markets and technologies for advanced drug delivery systems (ADDS) with a focus on the routes of administration (RoA)
In-depth analysis of global market trends, featuring historical revenue data for 2022-2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
Evaluation of the current market size and revenue growth prospects specific to the advanced drug delivery systems, accompanied by a market share analysis by route of administration, technology, application, vehicle/carrier and region
Analysis of current and future demand in the global advanced drug delivery systems market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
Analysis of drivers, challenges and opportunities affecting market growth
Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios and ESG trends of the market
Market share analysis of the key market participants in the advanced drug delivery systems market, along with their research priorities, product portfolios, global rankings and company competitive landscape
Company profiles of the leading global players, including AbbVie Inc., GSK plc, AstraZeneca, Novartis AG, Roche and Johnson & Johnson Services, Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics and Growth Factors
Emerging Technologies
Segmental Analysis
Regional Analysis
Conclusion
Chapter 2 Market Overview
Overview
Macroeconomic Factors Analysis
Impact of U.S. Tariffs on the Pharmaceutical Industry
Healthcare Expenditure
Aging Population
Geopolitical Risks, Trade Wars and Supply Chain Disruptions
Impact of Global Economic Growth (GDP) on the Pharma Sector
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Incidence of Chronic Diseases
Nanotechnology in Advancing Drug Delivery
Advances in Therapeutics and Material Science
Increasing R&D Spending by Companies
Rise in Government Funding and Pharmaceutical R&D Spending
Market Restraints
Route-Specific Barriers
Limitations with Nanotechnology and Nanoparticles
Challenges with Nano-drug Delivery
Market Opportunities
Cost-Efficiency of Advanced Drug Delivery Systems
Mechanism of Nanoparticles in Overcoming Drug Resistance
Emerging Markets
Chapter 4 Regulatory Landscape
Overview
The U.S.
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Pipeline Analysis
Overview
Artificial Intelligence (AI) and Machine Learning (ML)
3D Printing
Smart Drug Delivery System
Clinical Trial Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis by Status
Clinical Trials Analysis by Phase
Key Takeaways
Patent Analysis
Patents, by Leading Applicant
Patents, by Jurisdiction
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Advanced Drug Delivery Systems, by Route of Administration
Key Takeaways
Enteral Routes
Parenteral Routes
Respiratory Route
Transdermal Route
Implants
Ophthalmic
Others
Global Market for Advanced Drug Delivery Systems, by Technology
Key Takeaways
Targeted Release Drug Delivery
Extended Release Drug Delivery
Delayed Release Drug Delivery
Immediate Release Drug Delivery
Pulsatile Release Drug Delivery
Global Market for Advanced Drug Delivery Systems, by Vehicle/Carrier
Key Takeaways
Nanoparticles
Monoclonal Antibodies
Liposomes
Polymer Therapeutics
Prodrugs
Microparticles
Other Vehicles/Carriers
Global Market for Advanced Drug Delivery Systems, by Application
Key Takeaways
Oncology
Cardiovascular Diseases
Respiratory Diseases
Autoimmune Diseases
Inflammatory Diseases
Metabolic Diseases
Gastrointestinal Disorders
Ophthalmic
Other Applications
Geographic Breakdown
Global Market for Advanced Drug Delivery Systems, by Region
Key Takeaways
North America
Europe
Asia-Pacific
Middle East and Africa (MEA)
South America
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Landscape
Company Share Analysis
Chapter 8 Sustainability in the Advanced Drug Delivery Systems Market: An ESG Perspective
Introduction to ESG
Sustainability in the Advanced Drug Delivery Systems Market
ESG Perspective
Environmental Impact
Social Impact
Governance Impact
ESG Risk Ratings
Conclusion
Chapter 9 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ABBOTT
ABBVIE INC.
AMGEN INC.
ASTRAZENECA
BAXTER
BAYER AG
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
F. HOFFMANN-LA ROCHE LTD.
GILEAD SCIENCES INC.
GSK PLC
JAZZ PHARMACEUTICALS INC.
JOHNSON & JOHNSON
MERCK & CO. INC.
NOVARTIS AG
PFIZER INC.
SANOFI
Emerging Companies in the Advanced Drug Delivery Systems Market
